Valneva SE EBITDA vs. Revenue
| VLA Stock | EUR 1.89 0.12 5.97% |
For Valneva SE profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Valneva SE to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Valneva SE utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Valneva SE's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Valneva SE over time as well as its relative position and ranking within its peers.
Valneva |
Valneva SE Revenue vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. Valneva SE is rated first in ebitda category among its peers. It is rated first in revenue category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Valneva SE by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Valneva SE's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Valneva Revenue vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Valneva SE |
| = | (38.73 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Valneva SE |
| = | 348.08 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Valneva Revenue vs Competition
Valneva SE is rated first in revenue category among its peers. Market size based on revenue of Biotechnology industry is at this time estimated at about 599.69 Million. Valneva SE totals roughly 348.08 Million in revenue claiming about 58% of stocks in Biotechnology industry.
Valneva SE Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Valneva SE, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Valneva SE will eventually generate negative long term returns. The profitability progress is the general direction of Valneva SE's change in net profit over the period of time. It can combine multiple indicators of Valneva SE, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France. VALNEVA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 700 people.
Valneva Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Valneva SE. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Valneva SE position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Valneva SE's important profitability drivers and their relationship over time.
Use Valneva SE in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Valneva SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will appreciate offsetting losses from the drop in the long position's value.Valneva SE Pair Trading
Valneva SE Pair Trading Analysis
The ability to find closely correlated positions to Valneva SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Valneva SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Valneva SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Valneva SE to buy it.
The correlation of Valneva SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Valneva SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Valneva SE position
In addition to having Valneva SE in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Valneva Stock
To fully project Valneva SE's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Valneva SE at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Valneva SE's income statement, its balance sheet, and the statement of cash flows.